×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
FDA approves first treatment approved for stage 3 unresectable non-small cell lung cancer to reduce the risk of the cancer progressing, when the cancer has not worsened after chemoradiation.
Katie Kosko
A recent study showed that patients with head and neck cancer who had greater depressive symptoms had shorter survival, higher rates of chemoradiation interruption and poorer treatment response. However, there are ways to manage these symptoms. 
Katie Kosko
Adolescent cancer survivors can improve fitness, cognition and quality of life through increased physical activity, according to study findings presented ahead of the American Society of Clinical Oncology’s (ASCO) Cancer Survivorship Symposium.
More

Voices

Samira Rajabi
It's hard to stop comparing our sick bodies to the people around us, but once we do, as both patients and caretakers, we learn to honor our own experiences and value ourselves in new and beautiful ways.
Kim Johnson
When her sister had hit another roadblock in her treatment, Kim found something else  – a remarkable young man who changed her perception of caregiving.
Barbara Tako
Gratitude helps get this cancer survivor through her cancer days, fears and worries.
More

CURE Connections®

Heather Ambrose, Martha Raymond, and Tim Wert recognize unmet needs in the management of patients diagnosed with GI cancers.
Heather Ambrose, Martha Raymond, and Tim Wert highlight the pharmaceutical industry’s investment in conducting research and clinical trials to improve the care of patients impacted by GI cancers.
Experts Heather Ambrose and Tim Wert define the pharmaceutical industry’s role in the GI cancer space and discuss strategies to address educational barriers between patients and physicians.
More

Videos

William G. Wierda, M.D., Ph.D.
William G. Wierda, M.D., Ph.D., medical director of the Leukemia Center at The University of Texas MD Anderson Cancer Center, discusses how to best combine and sequence therapies for patients with chronic lymphocytic leukemia (CLL).
Joshua Richter, M.D.
A new patient-reported outcomes tool is helping to shift the way end-of-life and depression-related conversations are occurring between patients with multiple myeloma and their health care teams.
Michael J. Overman, M.D.
Genetic testing – particularly for microsatellite instability (MSI) – is an important step for all patients diagnosed with colorectal cancer.
More
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable